APA (7th ed.) Citation

Stanglmaier, M., Reis, S., & Hallek, M. (2004). Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells. Annals of Hematology, 83(10), 634. https://doi.org/10.1007/s00277-004-0917-0

Chicago Style (17th ed.) Citation

Stanglmaier, Michael, Simone Reis, and Michael Hallek. "Rituximab and Alemtuzumab Induce a Nonclassic, Caspase-independent Apoptotic Pathway in B-lymphoid Cell Lines and in Chronic Lymphocytic Leukemia Cells." Annals of Hematology 83, no. 10 (2004): 634. https://doi.org/10.1007/s00277-004-0917-0.

MLA (9th ed.) Citation

Stanglmaier, Michael, et al. "Rituximab and Alemtuzumab Induce a Nonclassic, Caspase-independent Apoptotic Pathway in B-lymphoid Cell Lines and in Chronic Lymphocytic Leukemia Cells." Annals of Hematology, vol. 83, no. 10, 2004, p. 634, https://doi.org/10.1007/s00277-004-0917-0.